Effects of anti-cancer agents on immunological status.
D000818:Animals; D000921:Antibody-Producing Cells / Q000187:drug effects; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001379:Azathioprine / Q000494:pharmacology; D003601:Cytotoxicity Tests, Immunologic; D004407:Dysgerminoma / Q000532:radiotherapy; D005455:Fluorescent Antibody Technique; D006801:Humans; D007109:Immunity / Q000187:drug effects* / Q000528:radiation effects; D007136:Immunoglobulins / Q000032:analysis; D037102:Lectins / Q000494:pharmacology; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000532:radiotherapy; D007958:Leukocyte Count; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000187:drug effects / Q000528:radiation effects*; D015122:Mercaptopurine / Q000494:pharmacology; D012756:Sheep / Q000276:immunology
D000970:Antineoplastic Agents; D007136:Immunoglobulins; D037102:Lectins; D015122:Mercaptopurine; D001379:Azathioprine